1,734 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Teva Pharmaceuticals is recalling 18,780 bottles of Metoprolol Succinate Extended-Release Tablets, 25 mg, distributed nationwide. The recall is due to failed dissolution specifications that could affect dosing. Patients should stop using affected bottles and contact Teva or their healthcare provider for guidance.
Bazic Products recalled Bazic Silicone Glue on January 29, 2026, due to a serious poisoning risk for children. The glue's packaging does not meet child-resistant standards, violating federal law. Consumers should stop using the product immediately and seek a full refund.
Mindbodygreen recalled Ultimate Multivitamin+ dietary supplements on January 29, 2026, due to a risk of child poisoning. The bottles lack child-resistant packaging, violating safety standards. Consumers should stop using the product immediately and secure it out of children's reach.
Viofairy recalled its Hair Growth Serum on January 29, 2026, due to serious poisoning risks. The packaging lacks required child-resistant features, endangering young children. Consumers must stop using the product immediately and secure it out of reach.
Nengmiaokeji recalled Sefudun 5% Minoxidil Hair Growth Serum Kit on January 29, 2026. The product lacks child-resistant packaging, posing a serious poisoning risk to children. Consumers should stop using the serum immediately and contact the company for a replacement.
Olympus Corporation of the Americas recalls 1,276 boxes of MAJ-1218 Single Use Biopsy Valve distributed nationwide to healthcare facilities. The device risks rubber fragment detachment during use. Stop using the device and follow the recall instructions from Olympus or your healthcare provider.
Teva Pharmaceuticals recalled 67,043 bottles of Metoprolol Succinate Extended-Release Tablets, 50 mg, distributed nationwide. The FDA enforcement report cites Failed Dissolution Specifications as the hazard. Health care providers and patients should stop using this product immediately and contact Teva for guidance.
Teva Pharmaceuticals recalled 7,448 bottles of Metoprolol Succinate Extended-Release Tablets nationwide after failed dissolution specifications were identified. The recall involves 100 mg, 100‑tablet bottles (NDC 45963-677-11) and 1,000‑tablet bottles (NDC 45963-677-96). The defect may affect drug release and efficacy. Patients should stop using affected bottles and contact Teva or their clinician
Ultradent Products recalled 2,508 Jiffy Original Composite Polisher Cups (Coarse) 12pk across multiple U.S. states. A defect causes cups to crumble and break apart, potentially delaying patient treatment. Clinicians should stop using the cups immediately and follow the manufacturer’s recall instructions.
Abiomed recalled 4,496 Impella RP Flex with SmartAssist devices. The recall cites a differential pressure sensor that may malfunction and drift readings. Stop using the device immediately and follow the manufacturer's recall instructions.
Abiomed recalled 179 Impella RP devices worldwide after a differential pressure sensor may drift. The fault can cause sensor values to drift, potentially affecting patient care. Stop using the device immediately and follow the recall instructions, including contacting Abiomed or your healthcare provider.
Abiomed recalled 291 Impella RP with SmartAssist devices sold worldwide, including the US. A differential pressure sensor may malfunction and cause readings to drift. Patients and healthcare providers should stop using the device immediately and follow the manufacturer’s recall instructions.
Asteria Health recalled 1,464 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. The recall affects products distributed nationwide. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Philips Medical Systems recalled 291 Azurion 3 M12 systems on January 26, 2026, due to a risk of unexpected table movement. This may occur when the Reset Geometry button is pressed, even if a table lock is active. The recall affects 27 units in the U.S. and 264 units internationally.
Philips Medical Systems Netherlands B.V. recalled 655 Azurion 7 B12 systems on January 26, 2026. The recall affects models 722067, 722225, and 722235 due to unexpected table movement when the Reset Geometry button is pressed. This poses a high risk of injury to patients and healthcare providers.
Asteria Health recalled 133 estradiol pellets on January 26, 2026, after detecting potential metal particulate matter. The recall, classified as Class II, affects pellets with lot number 253000126 and an expiration date of June 9, 2026. Consumers must stop using the product immediately and contact their healthcare provider for guidance.
Asteria Health recalled 60,868 testosterone pellets on January 26, 2026, due to contamination risks. The recall affects specific lots of the product that may contain metal particulate matter. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Asteria Health recalled 1,015 testosterone pellets on January 26, 2026 due to potential metal particulate contamination. The recall affects products distributed nationwide in the United States. Consumers must stop using the pellets immediately and contact their healthcare provider for guidance.
Asteria Health recalled 89,074 testosterone pellets on January 26, 2026. The recall stems from potential metal particulate contamination. Consumers must stop using the product and contact their healthcare provider immediately.
Asteria Health recalled 22,478 Estradiol 12.5 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers and healthcare providers must stop using the product immediately. The FDA classified this recall as Class II, indicating a high hazard level.
Radnostix, Inc. is recalling 16 units of SODIUM IODIDE I-131 Solution distributed nationwide in the United States and Puerto Rico. The product contains particulate matter due to production issues. Healthcare providers and patients should stop using the product immediately and await a recall notification by letter.
Asteria Health recalled 24,099 Estradiol, 10 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately. The recall affects pellets distributed nationwide in the USA.
Granules Pharmaceuticals Inc. recalled 71,424 bottles of Trazodone Hydrochloride on January 26, 2026. The recall stems from the presence of foreign tablets or capsules in the product. Consumers should stop using the medication immediately and consult their healthcare provider.
Philips Medical Systems recalled 326 Azurion 5 M12 systems on January 26, 2026. The table may move unexpectedly when the Reset Geometry button is pressed, posing a risk to patients and healthcare providers. Immediate cessation of use is advised.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.